Cargando…
Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial
Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypert...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681041/ https://www.ncbi.nlm.nih.gov/pubmed/31330767 http://dx.doi.org/10.3390/biom9070292 |
_version_ | 1783441641075376128 |
---|---|
author | Samaha, Ali A. Fawaz, Mirna Salami, Ali Baydoun, Safaa Eid, Ali H. |
author_facet | Samaha, Ali A. Fawaz, Mirna Salami, Ali Baydoun, Safaa Eid, Ali H. |
author_sort | Samaha, Ali A. |
collection | PubMed |
description | Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypertensive capacity of three of the most commonly used wild plant species Mentha longifolia, Viola odorata and Urtica dioica. Ethno-pharmacological data was collected by personal interviews with herbalists and traditional healers using a semi structured survey questionnaire and assessing relative frequency of citation (RFC). The clinical study was conducted by a randomized, blind, placebo-controlled trial in 29 subjects with mild hypertension distributed in four groups, three plant extract treatments and one placebo. Systolic (SBP) and diastolic blood pressures (DBP) as well as mean arterial blood pressures (MAP) were monitored at weeks 4, 8, 12 and 16 during the treatment with 300 mL/day of plant extract. Results showed that M. longifolia, U. dioica and V. odorata exhibited the highest values of RCF (0.95) followed by Allium ampeloprasum (0.94), Apium graveolens (0.92) and Crataegus azarolus (0.90). The clinical trial revealed dose- and duration-dependent significant reductions in SBP, DBP and MAP of subjects treated with M. longifolia, U. dioica or V. odorata. Our findings indicate that extracts of these plants present an effective, safe and promising potential as a phyto-therapuetical approach for the treatment of mild hypertension. More research on the phytochemistry, pharmacological effects and the underlying mechanisms is necessary. |
format | Online Article Text |
id | pubmed-6681041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66810412019-08-09 Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial Samaha, Ali A. Fawaz, Mirna Salami, Ali Baydoun, Safaa Eid, Ali H. Biomolecules Article Hypertension is highly prevalent among the Lebanese adult population and is indeed the major cause of mortality in Lebanon. Traditional use of antihypertensive medicinal plants has long been practiced. The aim of this study is to document this traditional knowledge and clinically test the antihypertensive capacity of three of the most commonly used wild plant species Mentha longifolia, Viola odorata and Urtica dioica. Ethno-pharmacological data was collected by personal interviews with herbalists and traditional healers using a semi structured survey questionnaire and assessing relative frequency of citation (RFC). The clinical study was conducted by a randomized, blind, placebo-controlled trial in 29 subjects with mild hypertension distributed in four groups, three plant extract treatments and one placebo. Systolic (SBP) and diastolic blood pressures (DBP) as well as mean arterial blood pressures (MAP) were monitored at weeks 4, 8, 12 and 16 during the treatment with 300 mL/day of plant extract. Results showed that M. longifolia, U. dioica and V. odorata exhibited the highest values of RCF (0.95) followed by Allium ampeloprasum (0.94), Apium graveolens (0.92) and Crataegus azarolus (0.90). The clinical trial revealed dose- and duration-dependent significant reductions in SBP, DBP and MAP of subjects treated with M. longifolia, U. dioica or V. odorata. Our findings indicate that extracts of these plants present an effective, safe and promising potential as a phyto-therapuetical approach for the treatment of mild hypertension. More research on the phytochemistry, pharmacological effects and the underlying mechanisms is necessary. MDPI 2019-07-20 /pmc/articles/PMC6681041/ /pubmed/31330767 http://dx.doi.org/10.3390/biom9070292 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Samaha, Ali A. Fawaz, Mirna Salami, Ali Baydoun, Safaa Eid, Ali H. Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title | Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title_full | Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title_fullStr | Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title_full_unstemmed | Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title_short | Antihypertensive Indigenous Lebanese Plants: Ethnopharmacology and a Clinical Trial |
title_sort | antihypertensive indigenous lebanese plants: ethnopharmacology and a clinical trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681041/ https://www.ncbi.nlm.nih.gov/pubmed/31330767 http://dx.doi.org/10.3390/biom9070292 |
work_keys_str_mv | AT samahaalia antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial AT fawazmirna antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial AT salamiali antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial AT baydounsafaa antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial AT eidalih antihypertensiveindigenouslebaneseplantsethnopharmacologyandaclinicaltrial |